Overview
Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.
Eligibility
Inclusion Criteria:
\- Patients under alirocumab 300mg treatment.
Exclusion Criteria:
- Age \< 18 years o \> 80 years;
- Patients who refuse to participate and to sign informed consent.